How should I start and titrate a vasopressin infusion in an adult septic shock patient whose mean arterial pressure remains below 65 mm Hg despite adequate fluid resuscitation and norepinephrine at 0.1–0.2 µg/kg/min?

Vasopressin Titration in Septic Shock

Add vasopressin at a fixed dose of 0.03–0.04 units/min when norepinephrine reaches 0.1–0.2 µg/kg/min and MAP remains below 65 mmHg despite adequate fluid resuscitation. 1

Pre-Vasopressin Requirements

Before initiating vasopressin, ensure the following baseline criteria are met:

• Fluid resuscitation: Administer at least 30 mL/kg of crystalloid within the first 3 hours 1
• Norepinephrine initiation: Start norepinephrine at 0.02 µg/kg/min via central venous access (or peripheral if central access is delayed), targeting MAP ≥ 65 mmHg 1
• Arterial line placement: Insert an arterial catheter for continuous blood pressure monitoring as soon as practical 1, 2

Vasopressin Dosing Protocol

Starting dose and titration:

• Fixed dose: 0.03 units/min (do not titrate) 1, 2, 3
• FDA-approved range for septic shock: 0.01–0.07 units/min 3
• Maximum dose ceiling: Do not exceed 0.03–0.04 units/min except as salvage therapy; higher doses cause cardiac, digital, and splanchnic ischemia without additional hemodynamic benefit 1, 2
• Never use as monotherapy: Vasopressin must always be added to norepinephrine, not used alone 1, 2

Threshold for adding vasopressin:

• Add when norepinephrine reaches 0.1–0.2 µg/kg/min (approximately 7–14 µg/min in a 70 kg patient) and MAP remains < 65 mmHg 1, 2
• The 2013 Surviving Sepsis Campaign guidelines state vasopressin can be added "with intent of either raising MAP or decreasing NE dosage" 1

Monitoring Beyond MAP

Vasopressor titration requires assessment of tissue perfusion markers every 2–4 hours, not just MAP targets:

• Lactate clearance: Obtain baseline and repeat within 6 hours; aim for normalization 1, 2
• Urine output: Maintain ≥ 0.5 mL/kg/h 1, 2
• Clinical perfusion markers: Mental status, skin perfusion, capillary refill 1, 2

Escalation Strategy for Refractory Shock

If MAP remains < 65 mmHg despite norepinephrine + vasopressin:

• Third-line agent: Add epinephrine starting at 0.05 µg/kg/min, titrating up to 0.3 µg/kg/min 2
• For persistent hypoperfusion with adequate MAP: Add dobutamine 2.5–20 µg/kg/min when cardiac dysfunction is evident (elevated filling pressures, low cardiac output) 1, 2
• Refractory shock after ≥ 4 hours: Consider hydrocortisone 200 mg/day IV (50 mg every 6 hours or continuous infusion) 1, 2

Critical Pitfalls to Avoid

• Do not exceed vasopressin 0.03–0.04 units/min: Higher doses increase ischemic complications (cardiac, digital, splanchnic) without benefit 1, 2
• Do not use dopamine: It is associated with 11% absolute increase in mortality and higher arrhythmia rates compared to norepinephrine 2
• Do not use phenylephrine as first-line: Reserved only for norepinephrine-induced serious arrhythmias, documented high cardiac output with persistent hypotension, or salvage therapy 1, 2
• Do not delay norepinephrine while pursuing aggressive fluid resuscitation: In severe hypotension with critically low diastolic pressure, early vasopressor use is appropriate 2

Weaning Strategy

When hemodynamic stability is achieved (MAP ≥ 65 mmHg for ≥ 2 hours with adequate tissue perfusion):

• Wean norepinephrine first: Reduce gradually by 0.02–0.05 µg/kg/min while keeping vasopressin at fixed 0.03 units/min 2
• Discontinue vasopressin last: Once norepinephrine is < 0.1 µg/kg/min and hemodynamics remain stable, discontinue vasopressin abruptly (do not taper) 2
• Withdrawing vasopressin before norepinephrine leads to greater hemodynamic instability 2

Special Considerations

Obstetric patients with septic shock:

• Start norepinephrine at 0.02 µg/kg/min; add vasopressin at 0.04 units/min if MAP remains inadequate despite norepinephrine 0.1–0.2 µg/kg/min 1
• Fetal monitoring is recommended when vasopressin is used, though it remains a reasonable second-line agent despite theoretical oxytocin receptor interaction 1

Patients with chronic hypertension:

• Target MAP of 70–85 mmHg instead of 65 mmHg to reduce need for renal replacement therapy 2